Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Leukemia, Myeloid, Acute 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Myelodysplastic Syndromes 48Multiple Myeloma 38Lymphoma 37Leukemia 35Lymphoma, Non-Hodgkin 29Leukemia, Lymphocytic, Chronic, B-Cell 24Hodgkin Disease 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hematologic Neoplasms 18Lymphoma, Large B-Cell, Diffuse 16Primary Myelofibrosis 11Neuroblastoma 11Leukemia, Myelomonocytic, Chronic 11Neoplasms, Plasma Cell 10Myeloproliferative Disorders 10Graft vs Host Disease 10Lymphoma, Follicular 9Leukemia, Biphenotypic, Acute 9Burkitt Lymphoma 8Neoplasms 7Lymphoma, Mantle-Cell 7Leukemia, Myelomonocytic, Juvenile 7Breast Neoplasms 6Rhabdoid Tumor 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, T-Cell 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

fludarabine phosphate 18Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 17Busulfan 17Tacrolimus 14Methotrexate 14Mycophenolic Acid 12Antilymphocyte Serum 12Cyclosporine 11Whole-Body Irradiation 9Filgrastim 7Etoposide 7Radiotherapy 6Methylprednisolone 6Melphalan 6Flow Cytometry 6Cord Blood Stem Cell Transplantation 6Therapeutics 4Sirolimus 4Psychiatric Rehabilitation 4thymoglobulin 3Rituximab 3Polymerase Chain Reaction 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Cyclosporins 3Aprepitant 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pdgfra-Associated Chronic Eosinophilic Leukemia × Stem Cell Transplantation × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡